Jung Yong Hong

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17

Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability–High Gastric Cancer

Minsuk Kwon, Minae An, Samuel J. Klempner et al. · Cancer Discovery · 2021 · 241 citations

Medicine, Immunology, Oncology +17

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial

Jeeyun Lee, Seung Tae Kim, Kyung Kim et al. · Cancer Discovery · 2019 · 234 citations

Medicine, Oncology, Pharmacology +17

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

Jung Yong Hong, Hee Jin Cho, K. Jason et al. · Genome Medicine · 2022 · 136 citations · Full text

Medicine, Immunology, Oncology +17

Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients

Jung Yong Hong, Eun Mi Nam, Jeeyun Lee et al. · Cancer Chemotherapy and Pharmacology · 2013 · 125 citations

Medicine, Oncology, Pharmacology +8